American Diversified Holdings Corporation (PK) (ADHC) News

Tomorrow I’ll buy at .0011 - .0012

$ADHC https://x.com/StockPicksNYC/status/1872285508644065641

Merry Christmas!!🎄❤️🙏🍸

Merry Christmas!!🎄❤️🙏🍸
Peace! Let 2024 be a Happy & Memorable year!
$ADHC $ASII $CGAC $CBTC $VTXB $HIRU $GRLT $RDAR $CNRC $SNWR $SINC $BEGI $ABQQ $TONR $IJJP $KGKG $CBIH $GGII $UBQU $HBRM $SNDL $SGD $AMTD $CNNA $CEIN $WNFT $PRDL $CBIA $MDCN $TMSH $INCC $SHIB-USD $CRO-USD $DJT

Management needs to put out a statement explaining how they are going to do all this.
1. How to pay for the clinical trials
2. How long for FDA approval
3. Will they apply for a patent
Looks like this will take a while even if everything goes good.
I am staying pat unless this goes back to .001 or less

Share Profile
Market Cap: Micro Cap
$1.64M
Shares Outstanding
1.26B
Shares held by Institutions..
Enterprise Value
$1.79M
How will they pay for those clinical trials??

Big name involved with GlucoGuard. As soon as the faucet in off position, should be free to roll.

I don't believe any patent board will give it a patent before it is declared safe and has FDA approval.

Since this device is targeted for humans and not pets it will most likely require a 3 phase clinical trial. That can take a long time. Another problem is getting volunteers to sign up understanding they are submitting to unknown risks, and then keeping them from dropping out of the program if they feel it is just too much of a burden and too lengthy, they may drop out and cause problems for the process to be completed. These are real issues the company needs to come clean about.

The average time for a medical device to go through an FDA clinical trial can vary significantly depending on the device's risk level, but generally takes several years with the process including preclinical research, clinical trials, submission of data to the FDA, and review by the agency before market approval; for less risky devices, the process may take a few months, while high-risk devices could take upwards of a decade.
How would you rate Glcoguard as far as risk goes. That is what the FDA process is all about.
The company needs to report back how long the FDA estimates Glucoguards time frame will take and even more important ,How much will it cost??

Who ever made that did a terrible job. It would be nice if the picture wasn't blurry so you could look that up on the internet. It's also misleading that is not Glucoguards device. Theirs looks like a mouth piece. I did take your advice and emailed the company about the break though device application and their patent number. No response as was expected.

https://x.com/markgoodsen/status/1871158763790487583

$ADHC https://x.com/MoMoney55648965/status/1871160778805465556

To be selling by the prior ceo

$ADHC We should be hearing from the Company anytime now!
https://x.com/StockPicksNYC/status/1869797933484265670

What debt exactly did they remove?? Using shares is not removing debt, it is just juggling the numbers to make it look that way.

What was this 9 day meeting all about??? Send in an application for what??? Clinical trials(Can take years) Patent application (Can take up to one year) No guarantees, just a first step.

What was the nine day meeting all about? Send in an application for what??? Clinical trials (can take years) Patent application (Can take up to a year) Either is time consuming and doesn't guarantee acceptance. It is just the first step.

According to this poster Remo converted to 2 billion shares. Maybe he can provide his source or link.
freecs Free 11/30/24 12:02 PM
Post #49,575
Remo has preferred. Converts to 2B shares. Yuck.

Not really. They lied about removing debt by doing a conversion to shares. CrownKing pumps always fail. Company has a long road to even getting a product to market if they ever do.

I like it!
Merry Christmas!

Again, why not contact the company directly, they're the sourse for your questions to be answered directly to you, so that there's no confusion, instead of you said, he said, they said etc...

I'm content with what I'm reading from the company's news/posts and I'm adding occasionally!

There is nothing to read. What you posted is just a rehash about a meeting to "finalize" an application. That was nine days ago, must be one heck of a long meeting. Did it get finalized? Did they send it in? By the look of the stock price not many believe so. 

BB; sorry I don't understand. Not enough volume for what?

dont think so not enough vol

BB_stock, there has been some discussion about the preferred shares situation given to the former CEO.
This link is from the quarterly report 12/03/24.
https://www.otcmarkets.com/otcapi/company/financial-report/418645/content
(Page 4 & 5)

As I read it Remo has 100,000 class C shares that he can covert to any amount of common so that the sale equals $2.7 million.
At todays price that over 1.5 billion common shares.
I have asked someone to check me but have had no reply.
Any response would be appreciated.

Absulutely.

grabbed some down here absolutely ridiculous

need to close above 200day .0015

Thats all I am asking for. Facts , not talk. They can easily post the patent number and it will aslo contain a comprehensive description of the product to make sure it is not infringing on someone elses patent. Thats why it takes so long to get a patent.
If it happens to get below .001, I will pick up more shares. Not willing to risk a lot of money in anything REMO has that many shares of.

lol, I had a pretty good size position I was exiting from. Maybe some of the selling has been tax selling, maybe not. You know that means little to me. The PA has been extremely weak for weeks now, which in turn has completely reset the chart. Maybe, just maybe today it see's a reversal and ends green. If that happen, i'll take back my trips comment. LOL

Ok....the office didn't pass along the memo....lol

Yeah, I bailed on the failed attempt to get back over .0025

I was hoping it was just tax loss selling....are you out

Well, you're surely not helping this selloff today.....lol

Stay clear from this one!  This one is heading back to trips.  Chart has been completely reset!  

You can call the sourse directly and ask them your questions. Instead of you said, I said, he said.
https://www.glucoguardsleep.com/how-it-works/

Viewmont what is your take on the preferred shares situation as stated in the last quarterly report 12/3/24?

https://www.otcmarkets.com/otcapi/company/financial-report/418645/content

It looks like we don't read the news or reports anymore.
They've been yelling that they're getting ready to submit it for FDA approval! LOL.
No need to do any DD, just rely on the next guy.

https://x.com/ADHCMANAGEMENT/status/1866858719339823271
https://x.com/ADHCMANAGEMENT/status/1867240173651611872

Not only a patent but I'd bet any medical device has to go through a FDA process. Don't take this wrong I'm not bashing matter of fact I own 2 million shares but it's time to show something concrete.

I agree. So far they don't have a patten. That process can take months even if they have a reasonably good product. Patten people are slow, they take their time.
Remo has well over a billon shares. Even though he has no voting rights and has to wait 6 months before he can sell his shares, that worries me. Sounds like he has more shares than any other investor and could cause a major dilution with that many shares. Just because I ask relevant questions doesn't make me a Basher.

Always do your own DD! Do not rely on anyone! https://x.com/viewmont12/status/1869535679065276507

https://x.com/ADHCMANAGEMENT

https://www.otcmarkets.com/stock/ADHC/profile

https://www.otcmarkets.com/stock/ADHC/news

https://www.otcmarkets.com/stock/ADHC/disclosure

ADHC, if you really do have a device, you should just show us the patent number and description that goes along with it.

TMaga; if memory serves, ADHC is looking to have an Investor Relations dept. starting in 2025.
I am exited about the possibilities here if they get breakthrough status, but the potential of someone being able to torpedo the price
would need to be addressed by IR.

Somehow REMO always finds a way to screw the shareholders.
Check his record for the last 10 to 20 years and see how many companies he destroyed.
According to:
freecs Free 11/30/24 12:02 PM
Post #49,575
Remo has preferred. Converts to 2B shares. Yuck.
If true, this is troublesome.

Some one please check me on this.

TMaga I hope you read the whole report.
Besides his Class B preferred, Remo was paid 100,000 Class C preferred shares (restricted) as payment of $2.6 million debt. (Aug 2024 spreadsheet page 5).
Go back to page 4 (for Class C) and if I read the conversion correctly, it is the amount of common shares it takes to equal $2.6M. At today's price that is well over a billion shares.
His Class B restriction limits him from owning more than 10% of the common stock but I see no such restriction for Class C.
That worries me.
I own no shares at this time.

I read that but my question is do they have a device yet?

Thank you for the information, much appreciated.
This guy has a history of doing some evil things causing investors to lose ALL THEIR MONEY, not just a portion.

from the quarterly report 12/3/24 (page 4)

https://www.otcmarkets.com/otcapi/company/financial-report/418645/content

On April 28, 2014, the Shareholder owned and held 100,000 shares of ADHC Series B Preferred
Stock, represented by Certificate Number 3 (50% - 200,000 shares authorized) which is
convertible into 10,000 shares of ADHC common stock per 1 share of ADHC Series B Preferred
Stock. However, Mr. Remo, our former Officer and Director, has executed a 9.99% Equity
Blocker with ADHC whereby he is prohibited from converting his Series B Preferred Stock of
the Company into Common Stock of the Company exceeding 9.99% of the Company’s current
issued and outstanding Common Stock, at the time of conversion. Therefore, at no time may he
own in excess of 9.99% of the issued and outstanding Common Stock of ADHC. This equity
blocker prohibits and restricts his ownership and voting rights. Currently Mr. Remo owns less
than 1% of the common stock of the Company.
Series Class C Convertible Preferred Stock
All 100,000 issued and outstanding Series Class C Convertible Preferred Stock have no
voting rights. The Conversion Rate shall be the number of common stock shares, at the
market price at an amount equal to the dollar amount due to the Stockholder at the time
of the conversion of debt to these Series Class C Convertible Preferred Stock. that
amount being the amount of $2,593,896 worth of common stock at the closing price of
the previous day. The debt amount will be removed from the financial statement at the
next quarterly filing

$ADHC Anyday now! Big Improvements in 2024! https://x.com/ADHCMANAGEMENT

https://x.com/viewmont12